COLART
Randomized, Double-blind Clinical Study to Evaluate the Effect of a Food Supplement Based on Hydrolyzed Collagen on Joint Function in a Moderately Active Population.
Sponsor study identifier
interventional
80
1 country
1
Study Start
April 1, 2023
Actual (reported)Primary Completion
February 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This clinical study evaluates the effect of taking a hydrolyzed collagen-based supplement on pain, function and quality of life in a moderately physically active population. Non-pathological knee pain is a common occurrence in many healthy people and can limit the quality of life. Therefore, the resolution of this problem can bring many benefits in terms of quality of life.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 1, 2023
Actual (reported)May 8, 2023
Actual (reported)June 26, 2023
Actual (reported)February 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Intensity of knee pain
It will be measured using a 100 mm long horizontal visual analogue scale (VAS) on which the participant must mark the pain he/she feels with 0 being "none" and 100 being "the most intense pain he/she can imagine". Once the level of pain is marked on the horizontal line, the length is measured from 0 in millimetres with a millimetre ruler. The results will be evaluated according to three levels of pain based on the marked values: \<40 mm: Values below 40 mm indicate mild or mild moderate pain 40-60 mm: If the measurement is between 40 and 60 mm, the pain is considered moderate to moderate-severe \>60 mm: If the values are greater than 60 mm, the pain is considered severe to unbearable.
Throughout study completion, an average of 12 weeks
Physical activity data
The following data will be recorded during the baseline visit
Subjects in this group will intake 10 g/day of a hydrolyzed collagen-based supplement.
Subjects in this group will intake 10 g/day of placebo (maltodextrin).
The collagen-based supplement will be ingested every day for 12 weeks at the same time.
The placebo will be ingested every day for 12 weeks at the same time.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Research Center for High Performance Sport. Catholic University of Murcia
La Ñora, Murcia, 30830, Spain
Francisco Javier Martínez Noguera, PhD
Research Center for High Performance Sport. Catholic University of Murcia
First Submitted
May 8, 2023
First Posted
June 26, 2023
Study Start
April 1, 2023
Actual (reported)Comparison of the Analgesic Effect of Subsartorial Saphenous Block and Popliteal Sciatic vs Subsartorial Saphenous Block and IPACK in Total Knee Replacement Surgery.
Use of Virtual Reality in Pain Management in Hospitalized Patients
Demographic data
The following data will be recorded during the baseline visit
Frequency of alcohol and tobacco consumption
The following data will be recorded during the baseline visit
Weight
The following data will be recorded during the baseline visit
Height
The following data will be recorded during the baseline visit
Contact the study team to confirm eligibility.
Primary Completion
February 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
July 6, 2023
Record last verified: 2023-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: